Merck
MRK
#62
Rank
C$344.32 B
Marketcap
C$137.85
Share price
-1.16%
Change (1 day)
-3.59%
Change (1 year)

P/S ratio for Merck (MRK)

P/S ratio as of December 2025 (TTM): 3.88

According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.80. At the end of 2025 the company had a P/S ratio of 3.05.

P/S ratio history for Merck from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.05-22.28%
20243.93-14.47%
20234.60-3.15%
20224.7519.38%
20213.97-13.85%
20204.61-6.41%
20194.935.25%
20184.6822.58%
20173.82-6.29%
20164.089.63%
20153.72-2.54%
20143.8214.68%
20133.3326.93%
20122.629.62%
20112.39-0.99%
20102.42-41.67%
20094.1453.66%
20082.69-48.35%
20075.2224.95%
20064.1832.42%
20053.151.89%
20043.09-32.21%
20034.5658.76%
20022.881.15%
20012.84

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.36-39.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.28 36.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.2 293.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.21-43.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.54-34.40%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
2.31-40.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
1.95-49.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
4.50 16.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
4.97 28.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
4.94 27.36%๐Ÿ‡บ๐Ÿ‡ธ USA